Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Mustang Bio Q3 EPS $(1.23) Misses $(1.11) Estimate

Author: Benzinga Newsdesk | November 14, 2023 06:06pm
Mustang Bio (NASDAQ:MBIO) reported quarterly losses of $(1.23) per share which missed the analyst consensus estimate of $(1.11) by 10.81 percent. This is a 54.44 percent increase over losses of $(2.70) per share from the same period last year.

Posted In: MBIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist